Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

Recruiting

Latanoprost vs. RocklatanMeasuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

Sponsor:

University of Maryland, Baltimore

Code:

NCT04401982

Conditions

Ocular Hypertension

Suspect Glaucoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rocklatan (Netarsudil 0.02%/ latanoprost 0.005)

Latanoprost (0.005%)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-03. This information was provided to ClinicalTrials.gov by University of Maryland, Baltimore on 2026-07-02.